Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Menopause affects hair and skin; more research needed for treatment.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Adrenal gland disease is common in ferrets and causes hair loss and other symptoms.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Healthcare providers need better education and policies to serve transgender individuals effectively.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Spironolactone plus finasteride works better for treating hirsutism.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Menopause can cause skin issues, and seeing a dermatologist helps.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

New treatments for long-lasting erections improve outcomes but must be timely to avoid lasting damage.